...
机译:具有新型糖酵解抑制剂PFK158的PFKFB3的治疗靶向促进妇科癌症的脂质和化学敏感性
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Division of Cardiovascular disease Department of MedicineMayo ClinicRochester MN;
Division of Gynecologic Surgery Department of Obstetrics and GynecologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
Division of Molecular MedicineUniversity of New Mexico School of MedicineAlbuquerque NM;
Department of MedicineUniversity of LouisvilleLouisville KY;
Department of MedicineUniversity of LouisvilleLouisville KY;
Advanced Cancer TherapeuticsLouisville KY;
Division of Cardiovascular disease Department of MedicineMayo ClinicRochester MN;
Department of Experimental PathologyMayo ClinicRochester MN;
ovarian and cervical cancer; Chemoresistance; PFKFB3; lipid droplet; lipophagy;
机译:具有新型糖酵解抑制剂PFK158的PFKFB3的治疗靶向促进妇科癌症的脂质和化学敏感性
机译:针对Warburg效应治疗癌症; 2-芳基吡啶并壬酮作为关键糖酵解酶6-磷酸果糖-2-激酶/ 2,6-双磷酸酶3(PFKFB3)抑制剂的关系
机译:MicroRNA-647促进氩链氦光滑的治疗效果,并通过非小细胞肺癌中的NF-κB信号传导途径靶向TRAF2,抑制细胞增殖
机译:基于结构的组织蛋白酶L抑制剂和治疗应用癌症转移和癌症诱导的骨质疏松症的治疗方法
机译:通过验证PARG作为治疗靶标并评估低氧诱导的转录的小分子抑制剂来设计新型癌症治疗剂。
机译:用新型糖酵解抑制剂PFK158靶向治疗PFKFB3可促进妇科癌症的脂肪吞噬和化学敏感性
机译:基于结构的小分子PFKFB3抑制剂的开发:针对Warburg效应的潜在癌症治疗剂的框架。